Emerging Strategies and Agents to Lower Cardiovascular Risk by Increasing High Density Lipoprotein Cholesterol Levels

E-ISSN： 1875-533x|16|2|144-156

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.2, 2009-01, pp. : 144-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic agents that raise high-density lipoprotein cholesterol levels

By Rodriguez Annabelle Doshi Rajiv R

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 167-175

Informa Healthcare

Access to resources Recommend Favorite

Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol

By Kashyap M.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 53-65

Adis International

Access to resources Recommend Favorite

Should We Take High-Density Lipoprotein Cholesterol Levels at Face Value?

By > >

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 1-3

Adis International

Access to resources Recommend Favorite

Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid

By Schachter Michael

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 415-422

Springer Publishing Company

Access to resources Recommend Favorite

Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1 1 Affiliation details for individual members of the HDL Forum are available in the Acknowledgments section.

By Juan F. Ascaso

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 299-314

Adis International

Access to resources Recommend Favorite